Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Evaluation of the safety of a novel peripheral vasopressor pilot program and the impact on central line placement in medical and surgical intensive care units.

Authors:
Kristen Marti Christopher Hartley Elizabeth Sweeney John Mah Nicholas Pugliese

Am J Health Syst Pharm 2022 May 23. Epub 2022 May 23.

Department of Pharmacy Services, Hartford Hospital, Hartford, CT.

Disclaimer: In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

Purpose: The purpose of this quality improvement project was to evaluate the safety and feasibility of peripheral vasopressor administration in an attempt to minimize the placement and improve early removal of unnecessary central lines to reduce central line-associated bloodstream infection (CLABSI) rates.

Methods: A retrospective chart review was conducted on patients who received vasopressors via peripheral infusion over 3 months, starting at the time of guideline implementation.

Results: We identified 129 vasopressor orders among 79 patients that were administered peripherally. Among these orders, 3 events were documented as possible extravasation events. Forty-five patients (57%) did not require central line placement due to increasing vasopressor requirements. Standard utilization ratio data suggest minimal central line impact of the protocol implementation. December 2020 to February 2021 was associated with a large second peak of coronavirus disease 2019 (COVID-19) in our region. Utilization of central lines was less than predicted in December 2020 to February 2021 in 2 of our 3 intensive care units (ICUs); however, the differences were statistically significant on only 3 occasions. In the third ICU, utilization was greater than predicted, but this unit housed a majority of the most critically ill patients with COVID-19.

Conclusion: This study suggests that short-term use of select vasopressors at conservative doses is safe for peripheral administration and points toward efficacy at preventing central line placement. Further analysis is required to confirm efficacy.

Download full-text PDF

 Source
http://dx.doi.org/10.1093/ajhp/zxac144DOI Listing
May 2022

Publication Analysis

Top Keywords

central placement
12
february 2021
8
care units
8
december 2020
8
central lines
8
peripheral vasopressor
8
2020 february
8
intensive care
8
central
7
orders events
4
peripherally orders
4
confirm efficacy
4
administered peripherally
4
patients administered
4
documented extravasation
4
orders patients
4
vasopressor orders
4
129 vasopressor
4
events documented
4
patients 57%
4

Keyword Occurance

Similar Publications

Phylogenomic loci define the generic boundaries of Gochnatieae and improve resolution at the species level in Moquiniastrum (Compositae).

Authors:
Morgan R Gostel Gisela Sancho Nádia Roque Mariano Donato Vicki A Funk

Mol Phylogenet Evol 2022 Jun 27:107558. Epub 2022 Jun 27.

United States National Herbarium, Department of Botany, National Museum of Natural History, Smithsonian Institution, MRC 166, Washington, D.C., 20560, USA.

Understanding the evolution of the tribe Gochnatieae (Compositae) has been the subject of considerable effort in the past decade. This is due to the key position of this tribe in the phylogeny of the sunflower family and the corresponding implications for biogeographic and morphological evolution of Compositae. Previous studies have confirmed the monophyly of this tribe as well as most of the genera that belong to it. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Simultaneous Alveolar Ridge Augmentation and Periodontal Regenerative Therapy Leveraging Recombinant Human Platelet-Derived Growth Factor-BB (rhPDGF-BB): A Case Report.

Authors:
Istvan A Urban Mustafa Tattan Andrea Ravida Muhammad Ha Saleh Lorenzo Tavelli Gustavo Avila-Ortiz

Int J Periodontics Restorative Dent 2022 Jun 30. Epub 2022 Jun 30.

Severe alveolar ridge deficiencies in concomitance with periodontal attachment loss can represent a serious clinical challenge in the context of implant therapy. The present case report describes the management of a complex defect in the esthetic zone via ridge augmentation and periodontal regenerative therapy using a biologic material. A systemically healthy 55-year-old man diagnosed with peri-implantitis around an implant in the maxillary left central incisor position and with severe bone loss on the mesial aspect of the maxillary left lateral incisor underwent several surgical interventions to achieve simultaneous vertical ridge augmentation and periodontal regeneration. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Inadvertent cannulation of subclavian artery in central venous catheter insertion: A case report and review of prevention and management.

Authors:
Wai Hung Lester Shiu

J Clin Imaging Sci 2022 17;12:34. Epub 2022 Jun 17.

Department of Radiology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.

Central venous catheter is a commonly performed procedure in which inadvertent arterial puncture is a known complication. Inadvertent arterial injury with a large-bore catheter is associated with significant morbidity and there are a few endovascular techniques to repair the injury, including the use of a percutaneous closure device and a covered stent placement. We report a case of a patient with complex medical history complicated by inadvertent right subclavian artery injury during central venous catheter insertion. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Risk of bleeding with dental implant surgery in patients on anticoagulant or antiplatelet drugs: a systematic review and meta-analysis.

Authors:
Lilin Zou Li Hua

Acta Odontol Scand 2022 Jun 28:1-7. Epub 2022 Jun 28.

Department of Stomatology, The First Affiliated Hospital of Soochow University, Suzhou, PR China.

Introduction: A large number of patients under oral anticoagulant (OAC) or antiplatelet (AP) therapy require dental implantation. We systematically reviewed evidence on the risk of bleeding after implant placement with continued OAC or AP therapy.

Methods: PubMed, Embase and CENTRAL were searched for studies comparing bleeding outcomes after implant placement between OAC/AP therapy . Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Narrow diameter implants to replace congenital missing maxillary lateral incisors: a 1-year prospective, controlled, clinical study.

Authors:
Andrea Roccuzzo Jean-Claude Imber Jakob Lempert Mandana Hosseini Simon Storgård Jensen

Clin Oral Implants Res 2022 Jun 28. Epub 2022 Jun 28.

Department of Oral and Maxillofacial Surgery, Copenhagen University Hospital, Copenhagen, Denmark.

Objectives: To report the clinical, radiographic, aesthetic and patient-reported outcomes after placement of a newly developed Narrow-Diameter Implant (NDI) in patients with congenitally Missing Lateral Incisors (MLIs).

Materials And Methods: Patients with MLIs with a mesio-distal distance between the canine and the central incisor of 5.9-6. Read More

View Article and Full-Text PDF
June 2022
Similar Publications
}